Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary
2011
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
2010 StandoutScienceNobel
Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP
2002
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein
2005 StandoutNobel
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy
2009 Standout
Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area
2003
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
2009 Standout
Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease
2005
Parkinson disease
2017 Standout
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
2007 Standout
p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism
2002
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Are Huntington’s and polyglutamine-based ataxias proteasome storage diseases?
2003
Sensitivity to MPTP is not increased in Parkinson's disease‐associated mutant α‐synuclein transgenic mice
2001
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
Pathological roles of MAPK signaling pathways in human diseases
2010 Standout
The role of autophagy in neurodegenerative disease
2013 Standout
Rotenone-Induced Apoptosis Is Mediated By p38 And JNK MAP Kinases In Human Dopaminergic SH-SY5Y Cells
2004
Genes and parkinsonism
2003
Traffic at the intersection of neurotrophic factor signaling and neurodegeneration
2003
PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
2010 Standout
Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation
2008
p53 protein, interferon-γ, and NF-κB levels are elevated in the parkinsonian brain
2006
Experimental models of Parkinson's disease
2001
Design and development of polymers for gene delivery
2005 Standout
LC3 conjugation system in mammalian autophagy
2004 Standout
Structure-Guided Directed Evolution of Highly Selective P450-Based Magnetic Resonance Imaging Sensors for Dopamine and Serotonin
2012 StandoutNobel
Epidemiology of Parkinson's disease
2006 Standout
Reactive Oxygen Species and p38 Mitogen-Activated Protein Kinase Activate Bax to Induce Mitochondrial Cytochrome c Release and Apoptosis in Response to Malonate
2006
Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease
2003
Role of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
2003 StandoutNobel
Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of γ‐synuclein, α‐synuclein and double α/γ‐synuclein null mutant mice
2004
Mitochondria Are a Major Source of Paraquat-induced Reactive Oxygen Species Production in the Brain
2007 Standout
Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations
2003
Diagnosis and initial management of cerebellar infarction
2008
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
2015 Standout
Protection by tetrahydroxystilbene glucoside against neurotoxicity induced by MPP+: The involvement of PI3K/Akt pathway activation
2011
SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson’s disease
2003
Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation
2003
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?
2004 Standout
Akt Suppresses Retrograde Degeneration of Dopaminergic Axons by Inhibition of Macroautophagy
2011
Blinded by the Light: The Growing Complexity of p53
2009 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein
2002
α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
2005 StandoutNobel
Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial
2015
Search-and-replace genome editing without double-strand breaks or donor DNA
2019 StandoutNature
The Glymphatic System: A Beginner’s Guide
2015 Standout
DJ-1 Decreases Bax Expression through Repressing p53 Transcriptional Activity
2007
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Neurotropic virus infections as the cause of immediate and delayed neuropathology
2015
Huntington's disease: The mystery unfolds?
2002
Neuronal cell death in Huntington’s disease: a potential role for dopamine
2000
The ubiquitin system: pathogenesis of human diseases and drug targeting
2004 StandoutNobel
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
2006 StandoutNature
Regulation of Dopaminergic Loss by Fas in a 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease
2004
Gene therapy progress and prospects: Parkinson's disease
2003
Very Small Cerebellar Infarcts: Integration of Recent Insights into a Functional Topographic Classification
2013 Standout
Effect of trehalose on protein structure
2008 Standout
Update on the pathogenesis of Parkinson’s disease
2008
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary
2011
Neuroglial activation and neuroinflammation in the brain of patients with autism
2004 Standout
Akt signalling in health and disease
2011 Standout
A ROCK inhibitor permits survival of dissociated human embryonic stem cells
2007 Standout
β-Carbolines induce apoptosis in cultured cerebellar granule neurons via the mitochondrial pathway
2004
Targeting programmed cell death in neurodegenerative diseases
2003
Neurodegenerative diseases and oxidative stress
2004 Standout
Oxidative stress and neurodegeneration: where are we now?
2006 Standout
Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors
2009 Standout
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease
2011
1 Caspase Inhibitors as Anti-inflammatory and Antiapoptotic Agents
2002
Pathogenic role of glial cells in Parkinson's disease
2002
Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: A review
2014 Standout
The debate over dopamine’s role in reward: the case for incentive salience
2006 Standout
Parkinson's Disease
2003 Standout
Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration
2006 Standout
Comparison of two independent aromatic hydroxylation assays in combination with intracerebral microdialysis to determine hydroxyl free radicals
2001
Mitochondrial Inhibition and Oxidative Stress: Reciprocating Players in Neurodegeneration
2005
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Stroke Risk After Posterior Circulation Stroke/Transient Ischemic Attack and its Relationship to Site of Vertebrobasilar Stenosis
2013
Neurons Expressing the Highest Levels of γ-Synuclein Are Unaffected by Targeted Inactivation of the Gene
2003
The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease.
2003
A Systematic Review of Stenting and Angioplasty of Symptomatic Extracranial Vertebral Artery Stenosis
2011
Tumor Necrosis Factor Death Receptor Signaling Cascade Is Required for Amyloid-β Protein-Induced Neuron Death
2004
Caspase Inhibitors Attenuate 1-Methyl-4-Phenylpyridinium Toxicity in Primary Cultures of Mesencephalic Dopaminergic Neurons
2002
The 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Mouse Model
2003
Guidelines for the Primary Prevention of Stroke
2014 Standout
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease
2006
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease
2001
BimEL up‐regulation potentiates AIF translocation and cell death in response to MPTP
2005
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
2004 StandoutScience
Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative disease
2007
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Oxidative stress in neurodegeneration: cause or consequence?
2004 Standout
Protein aggregation and degradation mechanisms in neurodegenerative diseases.
2013
Works of O. Eberhardt being referenced
Stenting of vertebrobasilar arteries in symptomatic atherosclerotic disease and acute occlusion: Case series and review of the literature
2006
Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson's disease
2003
Parkinson's disease: one biochemical pathway to fit all genes?
2002
Malonate‐Induced Generation of Reactive Oxygen Species in Rat Strium Depends on Dopamine Release but Not on NMDA Receptor Activation
1999
Protection by Synergistic Effects of Adenovirus-Mediated X-Chromosome-Linked Inhibitor of Apoptosis and Glial Cell Line-Derived Neurotrophic Factor Gene Transfer in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease
2000
HSV-2 sacral radiculitis (Elsberg syndrome)
2004